Skip to content
In deliveryUnited Kingdom

SECUKINUMAB 150 mg in 1mL Injection, SECUKINUMAB 300 mg in 2mL Solution for Injection

Published
Published 10 November 2025

Overview

Supply of SECUKINUMAB (COSENTYX) 150 mg in 1mL & 300mg in 2mL Injections to meet clinical need in the Western Trust until 30/11/2028.

Key details

Country
United Kingdom
Status
In delivery
Procedure
Direct
Published
10 November 2025

Award outcome

Awarded value
£4,638,166
Award date
10 November 2025
Contract period
1 December 2025 → 30 November 2028
Winner
  • NOVARTIS PHARMACEUTICALS UK LIMITED

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract

    8 December 2025

    View notice ↗
  2. Contract

    10 November 2025

    View notice ↗
  3. Contract

    10 November 2025

    View notice ↗

Contracting authority

  • Western Health & Social Care Trust

    Buyer

    Londonderry, United Kingdom

    GB-PPON: PTVW-2397-PWCT

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: SECUKINUMAB 150 mg in 1mL Injection, SECUKINUMAB 300 mg in 2mL Solution for Injection — won by NOVARTIS PHARMACEUTICALS UK LIMITED — Skim